SE8803567L - Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13) - Google Patents

Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13)

Info

Publication number
SE8803567L
SE8803567L SE8803567A SE8803567A SE8803567L SE 8803567 L SE8803567 L SE 8803567L SE 8803567 A SE8803567 A SE 8803567A SE 8803567 A SE8803567 A SE 8803567A SE 8803567 L SE8803567 L SE 8803567L
Authority
SE
Sweden
Prior art keywords
ppr
plasmid
beta
construction
size
Prior art date
Application number
SE8803567A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8803567D0 (sv
Inventor
V G Debabov
Original Assignee
Vnii Genetiki Selek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vnii Genetiki Selek filed Critical Vnii Genetiki Selek
Publication of SE8803567D0 publication Critical patent/SE8803567D0/xx
Publication of SE8803567L publication Critical patent/SE8803567L/

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8803567A 1987-02-09 1988-10-07 Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13) SE8803567L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU874191345A SU1703692A1 (ru) 1987-02-09 1987-02-09 Рекомбинантна плазмидна ДНК @ -1 @ 1-13, кодирующа синтез фибробластного интерферона ( @ I) человека, способ ее конструировани , штамм бактерий ЕSснеRIснIа coLI - продуцент @ I-интерферона человека

Publications (2)

Publication Number Publication Date
SE8803567D0 SE8803567D0 (sv) 1988-10-07
SE8803567L true SE8803567L (sv) 1988-10-07

Family

ID=21284355

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803567A SE8803567L (sv) 1987-02-09 1988-10-07 Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13)

Country Status (9)

Country Link
JP (1) JPH01502478A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH676996A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI884556A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2208866A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT50871A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8820103A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE8803567L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1703692A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1988005819A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219775T3 (de) * 1992-10-14 2004-08-05 Ajinomoto Co., Inc. Neuartiges L-threoninproduzierendes Mikrobakterium und eine Herstellungsmethode für L-Threonin
KR101128055B1 (ko) * 2004-12-20 2012-03-29 카딜라 핼쓰캐어 리미티드 고 수준의 인터페론 베타를 제조하는 방법
RU2386694C2 (ru) * 2006-05-05 2010-04-20 ООО "Биотех" Штамм дрожжей pichia pastoris - продуцент гамма-интерферона цыпленка, рекомбинантная плазмидная днк, обеспечивающая биосинтез гамма-интерферона цыпленка, и способ ее конструирования

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression

Also Published As

Publication number Publication date
FI884556A0 (fi) 1988-10-04
SE8803567D0 (sv) 1988-10-07
SU1703692A1 (ru) 1992-01-07
HUT50871A (en) 1990-03-28
JPH01502478A (ja) 1989-08-31
CH676996A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-03-28
WO1988005819A1 (fr) 1988-08-11
GB2208866A (en) 1989-04-19
FI884556A7 (fi) 1988-10-04
GB8823728D0 (en) 1988-12-07
NL8820103A (nl) 1989-01-02

Similar Documents

Publication Publication Date Title
EP0431541A3 (en) Toxoplasma gondii antigen, its production and use
IL83192A (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
AU580973B2 (en) Novel polypeptides with an ``-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products
CA2116774A1 (en) Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies
MA21323A1 (fr) Dihydrate d'azithromycine et son procede de preparation.
AU6244490A (en) Vaccine against lyme disease
DE3476896D1 (en) Production of protein a
HUT71193A (en) Tumor specific monoclonal antibody and cell line and pharmaceutical preparations containing them
CA2089753A1 (en) Interleukin-2-leukotoxin gene fusions and uses therefor
IL58872A (en) Process for producing 2,3,5-trichloropyridine and novel 2,4,4-trichloro-4-formylbutyronitrile intermediate used in the process and its preparation
AU1347688A (en) Viral antigen, process for its production, and application in diagnosis and therapy (vaccine)
JPS5726623A (en) Vaccine and manufacture
SE8803567L (sv) Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13)
FI102544B1 (fi) Menetelmä E.coli-kannan valmistamiseksi
AU548623B2 (en) Production of antibodies
NO180181C (no) Fremgangsmåte for fremstilling av et is-kjernedannende protein, plasmider og bakteriestammer
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
EP0293079A3 (en) Chlamydia vaccine
EP0407104A3 (en) Inorganically insulated heater, process for production thereof and cathode ray tube using the same
DE3279073D1 (en) Plasmid p sg 2 and process for its production
GR3007491T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
SE8803566L (sv) Rekombinantisk, maenniskointerleukin-2-syntesen kodande plasmid-dna av ppr-il2-19-typ, foerfarande foer konstruering av denna plasmid-dna och maenniskointerleukin-2-producerande, naemnda plasmid-dna innehaallande bakteriestam av kulturen escherichia coli vniigenetika vl 903 (ppr-il2-19)
AU7734687A (en) Novel substituted (4.2.0.)bicyclooctane derivatives with valuable therapeutic properties
IL82736A0 (en) Composite dna sequence,vectors,cells and bacterial strains comprising it and their use for the production of growth hormone

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8803567-0

Effective date: 19920901